Compare Oscar Health Inc (OSCR) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Ryanair Holdings plc — how do they compare? Oscar Health Inc trades at $33.4 (market cap $10.22B), while Ryanair Holdings plc trades at $54.39 (market cap $27.11B). The key difference: Ryanair Holdings plc is far larger — about 2.7× Oscar Health Inc's market cap, and Ryanair Holdings plc pays a 1.66% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Ryanair Holdings plc for 72 Days on average.
| OSCR | RYAAY | |
|---|---|---|
Market Cap | $10.22B | $27.11B |
Volume | 4,123,394 | 2,427,380 |
Sector | Health | Industrials |
52-Week High | $33.81 | $73.82 |
52-Week Low | $10.85 | $51.95 |
Typical Hold Time | 15 Days | 72 Days |
Enterprise Value | $6.57B | $24.18B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
RYAAY trades at $54.24, down 3.14% on the day, with a bearish technical signal from moving averages. The stock shows solid fundamentals with a P/E of 13.43 and net income margin of 12.13%, but recent earnings have missed expectations. Cash flow turned negative in 2025, and the company faces headwinds from high fuel costs and Boeing MAX 10 certification delays, as reported by Reuters on September 29, 2026.
The outlook is mixed: valuation appears attractive, and analyst consensus is moderately bullish with 64.71% buy ratings, but near-term risks from oil price volatility and operational challenges pressure the stock. Investors should weigh strong profitability and market position against earnings volatility and external uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
